Atlas Trials

Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease

Clinical trial NCT02157935 · COMPLETED

Trial details

NCT number
NCT02157935
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
COPD Patients
Start date
2014-06-27
Primary completion
2016-02-08
Enrollment
2026

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.